Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Acrylamide effects on the macaque visual system. I. Psychophysics and electrophysiology

Journal Article · · Invest. Ophthalmol. Visual Sci.; (United States)
OSTI ID:5963007
Oral acrylamide produces axonal swelling and later degeneration and gliosis in the distal optic tract, especially within the lateral geniculate nucleus, of macaque monkeys. Measures of visual thresholds and cortical-evoked potentials were used to study the time course of visual changes during exposure to acrylamide in macaque monkeys. Contrast sensitivity, visual acuity, and flicker fusion frequency were reduced during exposure, and only flicker fusion recovered rapidly and completely after exposure. Pattern-reversal-evoked responses exhibited increased latency and reduced amplitude during dosing but substantially recovered after exposure. Visual acuity and contrast sensitivity for high spatial frequencies were decreased throughout the 140 days of testing after dosing. These results suggest an acute general depression of visual capacities as the initial effect of acrylamide exposure, whereas later effects were confined to high spatial frequencies. 29 references, 6 figures.
Research Organization:
Univ. of Rochester Medical Center, NY
DOE Contract Number:
AC02-76EV03490
OSTI ID:
5963007
Journal Information:
Invest. Ophthalmol. Visual Sci.; (United States), Journal Name: Invest. Ophthalmol. Visual Sci.; (United States) Vol. 26:3; ISSN IOVSD
Country of Publication:
United States
Language:
English

Similar Records

Acrylamide-induced visual impairment in primates
Journal Article · Thu Dec 31 23:00:00 EST 1981 · Toxicol. Appl. Pharmacol.; (United States) · OSTI ID:5236802

Somatosensory thresholds in monkeys exposed to acrylamide
Journal Article · Fri Dec 31 23:00:00 EST 1982 · Toxicol. Appl. Pharmacol.; (United States) · OSTI ID:6962547

Spatial and temporal vision of macaques after central retinal lesions
Journal Article · Wed Jul 01 00:00:00 EDT 1981 · Invest. Ophthalmol. Visual Sci.; (United States) · OSTI ID:5239635